Home > Insider Trading > Filing (0001415889-24-013504)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	Pharmaceutical Preparations (2834)	812744449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1861684	R Joseph Young	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005	Svp, Finance, Chief Acct Offcr	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-05-15	8,221	$3.94	61,392	No	4	M	Direct
Class A Common Stock	Disposition	2024-05-15	8,221	$42.17	53,171	No	4	S	Direct
Class A Common Stock	Disposition	2024-05-15	1,965	$42.68	51,206	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-05-16	18,151	$7.87	69,357	No	4	M	Direct
Class A Common Stock	Disposition	2024-05-16	18,151	$42.22	51,206	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-05-16	2,500	$7.87	53,706	No	4	M	Direct
Class A Common Stock	Disposition	2024-05-16	2,500	$43.03	51,206	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (right to buy)	Disposition	2024-05-15	8,221	$0.00	8,221	$3.94
Class A Common Stock	Stock Option (right to buy)	Disposition	2024-05-16	20,651	$0.00	20,651	$7.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,589		2031-04-13	No	4	M	Direct
69,349		2033-02-14	No	4	M	Direct

Footnotes

The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.86, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.
1/48 of the total stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date.